MIR6834: A Potential Drug Target or Biomarker for Various Diseases
MIR6834: A Potential Drug Target or Biomarker for Various Diseases
MIR6834 (hsa-miR-6834-5p) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study, and several studies have investigated its potential clinical applications.
MIR6834 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. MiRNAs are designed to target specific mRNAs for degradation, and their levels are regulated by various factors, including translation efficiency, stability, and interactions with protein partners. MIR6834 is a part of the hsa-miR-68 family, which consists of 21 known miRNAs and several putative ones.
One of the most significant features of MIR6834 is its unique structure. It has a length of 20.5 nucleotides and consists of a single exon. The exon is located at position -6, and the 5' end is upstream of the gene. The 3' end is downstream of the gene, and there is a potential start site at position -3. The open reading frame (ORF) of MIR6834 starts at position -6 and ends at position -10.
MIR6834 has been shown to have various functions, including regulating gene expression, cell growth, and survival. One of the most well-studied functions of MIR6834 is its role in cell survival. Several studies have shown that MIR6834 can inhibit the cell cycle and cell survival by targeting the B-cell lymphoma (BCL) 1 (Bcl-1) gene. Bcl-1 is a protein that plays a crucial role in cell survival and has been implicated in various diseases, including cancer.
Another function of MIR6834 is its ability to regulate gene expression. Several studies have shown that MIR6834 can interact with various transcription factors, including NF-kappa-B, AP-1, and STAT3. These interactions can alter the activity of these transcription factors and ultimately regulate gene expression.
MIR6834 has also been shown to play a role in the regulation of cell adhesion. Several studies have shown that MIR6834 can interact with the protein Desmear, which is involved in cell adhesion. These interactions can alter the activity of Desmear and influence the formation of tight junctions, which are important for maintaining tissue structure and function.
In addition to its functions in cell survival and regulation, MIR6834 has also been shown to have potential clinical applications. Several studies have investigated the potential of MIR6834 as a drug target or biomarker for various diseases, including cancer. One of the most promising avenues for investigation is the use of small molecules to selectively target MIR6834 and enhance its expression levels.
Several studies have shown that MIR6834 can be targeted by small molecules, including inhibitors of the miRNA pathway and small molecule inhibitors of MIR6834 itself. These studies have led to the identification of several potential small molecules that can enhance the expression of MIR6834 and inhibit its degradation. Further studies are needed to determine the efficacy and safety of these small molecules as potential drug targets or biomarkers.
In conclusion, MIR6834 is a unique and highly promising molecule that has the potential to serve as a drug target or biomarker for various diseases. Its unique structure and function, as well as its potential clinical applications, make it an attractive target for further investigation. Further studies are needed to determine the efficacy and safety of small molecules that can enhance the expression of MIR6834 and inhibit its degradation.
Protein Name: MicroRNA 6834
The "MIR6834 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR6834 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR6836 | MIR6837 | MIR6839 | MIR6840 | MIR6841 | MIR6842 | MIR6843 | MIR6844 | MIR6845 | MIR6846 | MIR6847 | MIR6848 | MIR6849 | MIR6850 | MIR6851 | MIR6852 | MIR6853 | MIR6854 | MIR6855 | MIR6856 | MIR6857 | MIR6858 | MIR6859-1 | MIR6859-2 | MIR6859-3 | MIR6859-4 | MIR6860 | MIR6861 | MIR6862-1 | MIR6862-2 | MIR6863 | MIR6864 | MIR6865 | MIR6866 | MIR6867 | MIR6868 | MIR6869 | MIR6870 | MIR6871 | MIR6872 | MIR6873 | MIR6874 | MIR6875 | MIR6876 | MIR6877 | MIR6878 | MIR6879 | MIR6880 | MIR6881 | MIR6882 | MIR6883 | MIR6884 | MIR6885 | MIR6886 | MIR6887 | MIR6888 | MIR6889 | MIR6890 | MIR6891 | MIR6892 | MIR6893 | MIR6894 | MIR6895 | MIR7-1 | MIR7-2 | MIR7-3 | MIR7-3HG | MIR708 | MIR7106 | MIR7107 | MIR7108 | MIR7109 | MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114 | MIR7150 | MIR7151 | MIR7152 | MIR7153 | MIR7154 | MIR7155 | MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718 | MIR720 | MIR744 | MIR7515 | MIR758 | MIR759 | MIR760 | MIR761 | MIR762 | MIR762HG
